author-photo

María Remedios Marqués

University of Valencia

12

Papers

122

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.

2021 Thrombosis Research
Show All
- Source
- Cite
- Save
Citations (0)
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

2019 Thrombosis Research
Show All
- Source
- Cite
- Save
Citations (14)
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate®) and BAY 81-8973 (Kovaltry®) in patients with severe or moderate haemophilia A in prophylaxis

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (6)
SNPs and taxane toxicity in breast cancer patients

2014 Pharmacogenomics
Show All
- Source
- Cite
- Save
Citations (32)
Increased Hospital Stay and Allograft Disfunction in Renal Transplant Recipients with Cyp2c19 AA Variant in SNP rs4244285

2013 Drug Metabolism and Disposition
Show All
- Source
- Cite
- Save
Citations (14)
Renal Transplantation Recipients with AA Genotype in SNP rs4244285 of CYP2C19 Show An Increase in Hospital Stay Duration and Allograft Dysfunction Probably Due to Increased Tacrolimus Levels Caused by Interaction with Omeprazol: 1624

2012 Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Influence of Pharmacogenetic Polymorphisms in Routine Immunosuppression Therapy After Renal Transplantation

2010 Transplantation Proceedings
Show All
- Source
- Cite
- Save
Citations (13)
Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.

2008 Transplantation
Show All
- Source
- Cite
- Save
Citations (30)